Analysis of natural killer cells in TAP2-deficient patients: Expression of functional triggering receptors and evidence for the existence of inhibitory receptor(s) that prevent lysis of normal autologous cells

Blood

Volumn 99, Issue 5, 2002, Pages 1723-1729

  Vitale, Massimo ^a,b,c,d   Zimmer, Jacques ^a,b,c,d   Castriconi, Roberta ^a,b,c,d   Hanau, Daniel ^a,b,c,d   Donato, Lionel ^a,b,c,d   Bottino, Cristina ^a,b,c,d   Moretta, Lorenzo ^a,b,c,d   De La Salle, Henri ^a,b,c,d   Moretta, Alessandro ^a,b,c,d,e  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c ETABLISSEMENT FRANÇAIS DU SANG   (France)

^d HÔPITAL DE HAUTEPIERRE   (France)

^e Department of Experimental Medicine (DIMES)   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN CLASS 1; PHYTOHEMAGGLUTININ; PROTEIN; TRANSPORTER ASSOCIATED ANTIGEN PROCESSING PROTEIN 2; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXICITY; DOWN REGULATION; HLA SYSTEM; HUMAN; HUMAN CELL; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN DEFICIENCY;

EID: 0036493593     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V99.5.1723     Document Type: Article

References (40)

1. TAP1-dependent peptide translocation in vitro is ATP dependent and peptide selective
2. Selective and ATP-dependent translocation of peptides by the MHC-encoded transporter
3. Homozygous human TAP peptide transporter mutation in H LA class I deficiency
4. In search of the "missing self:" MHC molecules and NK cell recognition
5. Allorecognition by NK cells: Nonself or no self?
6. Self class I molecules protect normal cells from lysis mediated by autologous natural killer cells
7. Receptors for HLA-class I molecules in human natural killer cells
8. Regulation of immune responses through inhibitory receptors
9. The susceptibility to natural killer cell-mediated lysis of HLA class I-positive melanomas reflects the expression of insufficient amounts of HLA class I alleles
10. Activity and phenotype of natural killer cells in peptide transporter (TAP)-deficient patients (type I bare lymphocyte syndrome)
11. Association of a syndrome resembling Wegener's granulomatosis with low surface expression of HLA class-I molecules
12. Inefficient protection of human TAP-deficient fibroblasts from autologous NK cell-mediated lysis by cytokines inducing HLA class I expression
13. Human NK-cell receptors
14. P46, a novel natural killer cell-specific surface molecule which mediates cell activation
15. Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells
16. NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells is involved in non-MHC restricted tumor cell lysis
17. Activating receptors and co-receptors involved in human natural killer cell-mediated cytolysis
18. Two subsets of human T lymphocytes expressing antigen receptor are identified by monoclonal antibodies directed to two distinct molecular forms of the receptor
19. 2B4 functions as a co-receptor in human natural killer cell activation
20. NKp44, a triggering receptor involved in tumor cell lysis by activated human natural killer cells, is a novel member of the immunoglobulin superfamily
21. Identification of NKp80, a novel triggering molecule expressed by human natural killer cells
22. Role of NKG2-D in tumor cell lysis mediated by human NK cells: Cooperation with natural cytotoxicity receptors and capability of recognizing tumors of nonepithelial origin
23. Identification and molecular cloning of p75/AIRM1, a novel member of the sialoadhesin family which functions as an inhibitory receptor in human natural killer cells
24. Molecular and functional characterization of IRp60, a member of the immunoglobulin superfamily that functions as an inhibitory receptor in human natural killer cells
25. Molecular cloning of NKp46: A novel member of the immunoglobulin superfamily involved in triggering of natural cytotoxicity
26. NKp46 is the major triggering receptor involved in the natural cytotoxicity of fresh or cultured human natural killer cells: Correlation between surface density of NKp46 and natural cytotoxicity against autologous, allogeneic or xenogeneic target cells
27. Human peptide transporter deficiency: Importance of HLA-B in the presentation of TAP-independent EBV antigens
28. Implications for immunosurveillance of altered HLA-class I phenotypes in human tumours
29. Comparative studies of human FcRIII-positive and negative natural killer cells
30. Expression of a functional c-kit receptor on a subset of natural killer cells
31. bright natural killer cell subsets: Characterization of distinct functional responses to interleukin-2 and the c-kit ligand
32. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA
33. Novel surface molecules involved in human NK cell activation and triggering of the lytic machinery
34. Identification of a novel signal transduction surface molecule on human cytotoxic lymphocytes
35. Molecular cloning and biological characterization of NK cell activation-inducing ligand, a counter structure for CD48
36. Activating interactions in human NK cell recognition: The role of 2B4-CD48
37. Beta2-microglobulin-deficient NK cells show increased sensitivity to MHC class I-mediated inhibition, but self tolerance does not depend upon target cell expression of H-2Kb and Db heavy chains
38. Fine tuning of natural killer cell specificity and maintenance of self-tolerance in MHC class I-deficient mice
39. P40, a novel surface molecule involved in the regulation of the non-MHC restricted cytolytic activity in humans
40. LAIR-1, a novel inhibitory receptor expressed on human mononuclear leukocytes